Centocor Ortho Biotech
Bridgewater
About Centocor Ortho Biotech
Centocor is an integrated biopharmaceutical company developing monoclonal antibody-based products for cardiovascular and autoimmune diseases, cancer and inflammation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10M+
- Funding stage: M&A
- Last round: Seed (Jan 1980)
- Website: janssenbiotech.com
- Phone: (908)541-4000
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/centocor-ortho-biotech-3354679 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.